A real kick in the femur

One high profile lawsuit is a crisis for a drug manufacturer but 5,000 is a catastrophe! Three years after a federal judge dismissed lawsuits against Fosamax, an osteoporosis prevention drug from Merck, (apparently 5,000 fractured femurs didn’t constitute ‘clear evidence’ of a negative side effect) an appeals court has ruled that Merck will indeed be back in the courtroom. Ouch. It’s not like Merck hasn’t been here before, settling for more than $27 million with 1,200 patients who endured jawbone necrosis while taking Fosamax. Instead of the “cure,” perhaps a pound of prevention—in the form of these foods—is in order?

Now don't be stingy. Share this.Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn